Lista de obras -

A phase 4, randomised, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

scientific article published on 16 September 2020

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study

artículo científico publicado en 2018

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials

scientific article published on 14 August 2019

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

artículo científico publicado en 2016

Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways

scientific article published on 01 July 2019

Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus

scientific article published on 20 September 2018

Determinants of costs and benefits in psoriasis routine care: Results from a cross-sectional nationwide study in Germany

artículo científico publicado en 2020

Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture

artículo científico publicado en 2015

Genome-wide association analysis identifies three psoriasis susceptibility loci

scientific journal article

Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

artículo científico publicado en 2010

Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL

scientific journal article

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

artículo científico publicado en 2012

Psoriasis, stress, age and more

artículo científico publicado en 2018

Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention.

artículo científico publicado en 2018

Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study

scientific article published on 17 October 2019

Secukinumab Demonstrates High Sustained Efficacy and a Favorable Safety Profile in Patients with Moderate to Severe Psoriasis through 5 Years of Treatment (SCULPTURE Extension Study).

artículo científico publicado en 2018

Strategies to reduce stigma related to visible chronic skin diseases: a systematic review

scientific article published on 05 August 2019

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis

artículo científico publicado en 2019

The Effect of Tamol on Human Mast Cell Chymase and Plasmin ⬇️

artículo científico publicado el 1 de enero de 1997

The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis

artículo científico publicado en 2020

Toxic inner ear damage in topical treatment of psoriasis with salicylates ⬇️

artículo científico publicado el 1 de junio de 1997

Lista de obras de

A phase 4, randomised, head-to-head trial comparing the efficacy of subcutaneous injections of brodalumab to oral administrations of fumaric acid esters in adults with moderate-to-severe plaque psoriasis (CHANGE)

ALIGNed on adherence: subanalysis of adherence in immune-mediated inflammatory diseases in the DACH region of the global ALIGN study

Adalimumab medium-term dosing strategy in moderate-to-severe hidradenitis suppurativa: integrated results from the phase III randomized placebo-controlled PIONEER trials

Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci

Clinical response of psoriasis to subcutaneous methotrexate correlates with inhibition of cutaneous T helper 1 and 17 inflammatory pathways

Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus

Determinants of costs and benefits in psoriasis routine care: Results from a cross-sectional nationwide study in Germany

Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture

Genome-wide association analysis identifies three psoriasis susceptibility loci

Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2

Genome-wide meta-analysis of psoriatic arthritis identifies susceptibility locus at REL

Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity.

Psoriasis, stress, age and more

Psychosocial Distress of Patients with Psoriasis: Protocol for an Assessment of Care Needs and the Development of a Supportive Intervention.

Quality of life outcomes in adults with moderate-to-severe plaque psoriasis treated with dimethylfumarate (DMF): a post hoc analysis of the BRIDGE study

Secukinumab Demonstrates High Sustained Efficacy and a Favorable Safety Profile in Patients with Moderate to Severe Psoriasis through 5 Years of Treatment (SCULPTURE Extension Study).

Strategies to reduce stigma related to visible chronic skin diseases: a systematic review

Switching from a fumaric acid ester mixture to dimethylfumarate monotherapy in psoriasis

The Effect of Tamol on Human Mast Cell Chymase and Plasmin ⬇️

The role of the interleukin-23/Th17 pathway in cardiometabolic comorbidity associated with psoriasis

Toxic inner ear damage in topical treatment of psoriasis with salicylates ⬇️